SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 197.12 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 24.98 |
| Book Value / Share | 0.24 |
| Price / Book | n/a |
| NCAV ($M) | 10.54 |
| NCAV / Share | 0.10 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.56 |
| Return on Assets (ROA) | -0.17 |
| Return on Equity (ROE) | -0.58 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.33 |
| Current Ratio | 2.33 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 92.41 |
| Assets | 106.85 |
| Liabilities | 81.87 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Van Herk Investments B.v. | 10.90 | 40.29 | |
| 13G | Adage Capital Management, L.P. | 9.30 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 198,587 | 672,024 | 29.55 | |
| 40,736 | 370,125 | 11.01 | |
| 389,215 | 827,334 | 47.04 | |
| 521,447 | 1,346,756 | 38.72 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PRFX – PainReform Ltd. | PROK – ProKidney Corp. |
| PRPH – ProPhase Labs, Inc. | PRTG – Portage Biotech Inc. |
| PTIX – Protagenic Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io